标题
Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation
作者
关键词
-
出版物
Frontiers in Immunology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-03-09
DOI
10.3389/fimmu.2021.636568
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The SPPL3-defined glycosphingolipid repertoire orchestrates HLA class I-mediated immune responses
- (2021) Marlieke L.M. Jongsma et al. IMMUNITY
- Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal cancer
- (2020) Jin Zhao et al. CANCER LETTERS
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- A genome-wide transcriptomic analysis of protein-coding genes in human blood cells
- (2020) Mathias Uhlen et al. SCIENCE
- Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy
- (2020) Yuanlin Wu et al. PHARMACOLOGICAL RESEARCH
- Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
- (2020) Jenny H. Lee et al. Nature Communications
- Oncoprotein SND1 hijacks nascent MHC-I heavy chain to ER-associated degradation, leading to impaired CD8+ T cell response in tumor
- (2020) Yuan Wang et al. Science Advances
- Long Non-coding RNA LINC02195 as a Regulator of MHC I Molecules and Favorable Prognostic Marker for Head and Neck Squamous Cell Carcinoma
- (2020) Hao Li et al. Frontiers in Oncology
- Genome-wide methylation patterns predict clinical benefit of immunotherapy in lung cancer
- (2020) Jeong Yeon Kim et al. Clinical Epigenetics
- Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma
- (2020) Catherine S. Grasso et al. CANCER CELL
- CAR-NK cells: A promising cellular immunotherapy for cancer
- (2020) Guozhu Xie et al. EBioMedicine
- Identification of microRNAs Targeting the Transporter Associated with Antigen Processing TAP1 in Melanoma
- (2020) Maria-Filothei Lazaridou et al. Journal of Clinical Medicine
- Expression of human leukocyte antigen class I and β2‐microglobulin in colorectal cancer and its prognostic impact
- (2020) Hee Young Na et al. CANCER SCIENCE
- Differential modulation and prognostic values of immune-escape genes in uveal melanoma
- (2019) Maria Sofia Basile et al. PLoS One
- The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
- (2019) Fernando Souza-Fonseca-Guimaraes et al. TRENDS IN IMMUNOLOGY
- Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
- (2019) Daisuke Ennishi et al. Cancer Discovery
- MHC Class 1 and PDL-1 Status of Primary Tumor and Lymph Node Metastatic Tumor Tissue in Gastric Cancers
- (2019) Ibrahim Halil Erdogdu Gastroenterology Research and Practice
- Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin
- (2019) Ida Hafstrand et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series
- (2019) Selma Ugurel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy
- (2019) Debarati Banik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cellular functions of long noncoding RNAs
- (2019) Run-Wen Yao et al. NATURE CELL BIOLOGY
- Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy
- (2019) Abdullah Al Emran et al. TRENDS IN IMMUNOLOGY
- Downregulated expression of human leukocyte antigen class I heavy chain is associated with poor prognosis in non‑small‑cell lung cancer
- (2019) Kazuomi Ichinokawa et al. Oncology Letters
- TEIPP peptides: exploration of unTAPped cancer antigens
- (2019) Koen A. Marijt et al. OncoImmunology
- DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade
- (2019) Guo-Liang Chew et al. DEVELOPMENTAL CELL
- Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression
- (2019) Qingsong Hu et al. NATURE IMMUNOLOGY
- Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells
- (2019) Tessa Knox et al. Scientific Reports
- Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients
- (2019) Shin Hye Yoo et al. Scientific Reports
- Tumor intrinsic immunity related proteins may be novel tumor suppressors in some types of cancer
- (2019) Donghai Xiong et al. Scientific Reports
- Histone-deacetylase inhibition sensitizes PD1 blockade-resistant B-cell lymphomas
- (2019) Xiaoguang Wang et al. Cancer Immunology Research
- Does Natural Killer Cell Deficiency (NKD) Increase the Risk of Cancer? NKD May Increase the Risk of Some Virus Induced Cancer
- (2019) Won Young Moon et al. Frontiers in Immunology
- Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling
- (2019) Koen A. Marijt et al. Journal for ImmunoTherapy of Cancer
- An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer
- (2019) Marian L. Burr et al. CANCER CELL
- Tumor mutation burden: from comprehensive mutational screening to the clinic
- (2019) Francesca Galuppini et al. Cancer Cell International
- Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells
- (2019) Matthew B. Dong et al. CELL
- Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer
- (2019) Jhanelle E. Gray et al. CLINICAL CANCER RESEARCH
- Targeting EZH2 enhances antigen presentation, antitumor immunity and circumvents anti-PD-1 resistance in head and neck cancers
- (2019) Liye Zhou et al. CLINICAL CANCER RESEARCH
- Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 Expression
- (2019) Barry A. Kriegsman et al. JOURNAL OF IMMUNOLOGY
- Combination PD-1 and PD-L1 Blockade Promotes Durable Neoantigen-Specific T Cell-Mediated Immunity in Pancreatic Ductal Adenocarcinoma
- (2019) Adam L. Burrack et al. Cell Reports
- ALK and RET inhibitors promote HLA class I antigen presentation and unmask new antigens within the tumor immunopeptidome
- (2019) Claire Y Oh et al. Cancer Immunology Research
- The Role of Non-coding RNAs in Oncology
- (2019) Frank J. Slack et al. CELL
- Cancer immune escape: MHC expression in primary tumours versus metastases
- (2019) Federico Garrido et al. IMMUNOLOGY
- Endogenous T cells prevent tumor immune escape following adoptive T cell therapy
- (2019) Scott R. Walsh et al. JOURNAL OF CLINICAL INVESTIGATION
- HLA and proteasome expression body map
- (2018) Sebastian Boegel et al. BMC Medical Genomics
- Defective HLA class I antigen processing machinery in cancer
- (2018) Lei Cai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Anti-tumor Immune Response and Poor Outcomes of Patients
- (2018) Luigi Mari et al. GASTROENTEROLOGY
- Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
- (2018) Shetal A. Patel et al. IMMUNITY
- Cancer in primary immunodeficiency diseases: Cancer incidence in the United States Immune Deficiency Network Registry
- (2018) Paul C. Mayor et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
- (2018) Deng Pan et al. SCIENCE
- MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
- (2018) Scott J. Rodig et al. Science Translational Medicine
- DNA methyltransferase inhibition upregulates MHC-I to potentiate cytotoxic T lymphocyte responses in breast cancer
- (2018) Na Luo et al. Nature Communications
- DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
- (2018) Varun Sasidharan Nair et al. Clinical Epigenetics
- MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy
- (2018) Irene Romero et al. Frontiers in Immunology
- Complex pattern of immune evasion in MSI colorectal cancer
- (2018) Mine Ozcan et al. OncoImmunology
- HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15
- (2018) María A. Garrido et al. IMMUNOGENETICS
- Genetics of antigen processing and presentation
- (2018) Adrian Kelly et al. IMMUNOGENETICS
- The immunoproteasome and thymoproteasome: functions, evolution and human disease
- (2018) Shigeo Murata et al. NATURE IMMUNOLOGY
- Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA
- (2018) K. G. Paulson et al. Nature Communications
- Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges
- (2018) Aifen Lin et al. Frontiers in Immunology
- Cancer Neoantigens
- (2018) Ton N. Schumacher et al. Annual Review of Immunology
- Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma
- (2018) Diwakar Davar et al. JOURNAL OF CLINICAL ONCOLOGY
- Creation of versatile cloning platforms for transgene expression and dCas9-based epigenome editing
- (2018) Jonathan M Haldeman et al. NUCLEIC ACIDS RESEARCH
- Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours
- (2018) Aurélie Durgeau et al. Nature Communications
- Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Non-randomized, Open-label, Phase 2 Study
- (2018) Naval Daver et al. Cancer Discovery
- New Insights Into the Role of Qa-2 and HLA-G Non-classical MHC-I Complexes in Malignancy
- (2018) Istéfani L. da Silva et al. Frontiers in Immunology
- DNA methylation of immune checkpoints in the peripheral blood of breast and colorectal cancer patients
- (2018) Asma A. Elashi et al. OncoImmunology
- High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
- (2018) Saman Maleki Vareki Journal for ImmunoTherapy of Cancer
- The MEK Inhibitors Trametinib and Cobimetinib Induce a Type I Interferon Response in Human Keratinocytes
- (2017) Daniela Lulli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Varied Role of Ubiquitylation in Generating MHC Class I Peptide Ligands
- (2017) Jiajie Wei et al. JOURNAL OF IMMUNOLOGY
- The regulatory network behind MHC class I expression
- (2017) Marlieke L.M. Jongsma et al. MOLECULAR IMMUNOLOGY
- Structure of the human MHC-I peptide-loading complex
- (2017) Andreas Blees et al. NATURE
- Identification of essential genes for cancer immunotherapy
- (2017) Shashank J. Patel et al. NATURE
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- (2017) Robert T. Manguso et al. NATURE
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
- (2017) Meredith L. Stone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
- (2017) Diego Chowell et al. SCIENCE
- Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions
- (2017) Antje Sucker et al. Nature Communications
- Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
- (2017) Martin Lauss et al. Nature Communications
- Resistance to checkpoint blockade therapy through inactivation of antigen presentation
- (2017) Moshe Sade-Feldman et al. Nature Communications
- Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer
- (2017) Scott Gettinger et al. Cancer Discovery
- Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the JAK2 gene in non-small cell lung cancer
- (2017) Tao Shen et al. Oncotarget
- HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model
- (2017) Barbara Schrörs et al. Oncotarget
- HDAC inhibition potentiates immunotherapy in triple negative breast cancer
- (2017) Manuela Terranova-Barberio et al. Oncotarget
- The Role of HLA-Class Ib Molecules in Immune-Related Diseases, Tumors, and Infections 2016
- (2017) Roberta Rizzo et al. Journal of Immunology Research
- NK Cell Exhaustion
- (2017) Jiacheng Bi et al. Frontiers in Immunology
- Canonical and Non-Canonical Aspects of JAK–STAT Signaling: Lessons from Interferons for Cytokine Responses
- (2017) Andrea Majoros et al. Frontiers in Immunology
- TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer
- (2017) Agnes Ling et al. OncoImmunology
- Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors
- (2017) Martin H. Pedersen et al. OncoImmunology
- Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition
- (2017) Yosuke Shionoya et al. OncoImmunology
- Nuclear IRF-1 expression as a mechanism to assess “Capability” to express PD-L1 and response to PD-1 therapy in metastatic melanoma
- (2017) James W. Smithy et al. Journal for ImmunoTherapy of Cancer
- Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma
- (2017) Cathrin Ritter et al. Scientific Reports
- Expression of PD-L1 and HLA Class I in Esophageal Squamous Cell Carcinoma: Prognostic Factors for Patient Outcome
- (2016) Shuhei Ito et al. ANNALS OF SURGICAL ONCOLOGY
- Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer
- (2016) Hirofumi Matsumoto et al. BREAST CANCER RESEARCH AND TREATMENT
- Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
- (2016) Jianjun Gao et al. CELL
- Rs56288038 (C/G) in 3'UTR of IRF-1 Regulated by MiR-502-5p Promotes Gastric Cancer Development
- (2016) Bo Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- ERAAP Shapes the Peptidome Associated with Classical and Nonclassical MHC Class I Molecules
- (2016) Niranjana A. Nagarajan et al. JOURNAL OF IMMUNOLOGY
- Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype
- (2016) Marie Kostine et al. MODERN PATHOLOGY
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells
- (2016) Yihe Yan et al. ONCOLOGY REPORTS
- NLRC5/MHC class I transactivator is a target for immune evasion in cancer
- (2016) Sayuri Yoshihama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer
- (2016) T Colangelo et al. Cell Death & Disease
- Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells
- (2016) E. J. Brea et al. Cancer Immunology Research
- Cancers Related to Immunodeficiencies: Update and Perspectives
- (2016) Esmaeil Mortaz et al. Frontiers in Immunology
- Epigenetic Changes within the Promoter Regions of Antigen Processing Machinery Family Genes in Kazakh Primary Esophageal Squamous Cell Carcinoma
- (2015) Ilyar Sheyhidin et al. Asian Pacific Journal of Cancer Prevention
- The transporter associated with antigen processing: a key player in adaptive immunity
- (2015) Sabine Eggensperger et al. BIOLOGICAL CHEMISTRY
- HLA class I is most tightly linked to levels of tapasin compared with other antigen-processing proteins in glioblastoma
- (2015) Camilla Thuring et al. BRITISH JOURNAL OF CANCER
- Frequent HLA class I alterations in human prostate cancer: molecular mechanisms and clinical relevance
- (2015) Francisco Javier Carretero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- Multiple Structural and Epigenetic Defects in the Human Leukocyte Antigen Class I Antigen Presentation Pathway in a Recurrent Metastatic Melanoma Following Immunotherapy
- (2015) Chien-Chung Chang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Landscape of Tumor Antigens in T Cell Immunotherapy
- (2015) S. Ilyas et al. JOURNAL OF IMMUNOLOGY
- Loss of tapasin correlates with diminished CD8+ T-cell immunity and prognosis in colorectal cancer
- (2015) Lena Sokol et al. Journal of Translational Medicine
- Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers
- (2015) Isaac B Hilton et al. NATURE BIOTECHNOLOGY
- Active immunosurveillance in the tumor microenvironment of colorectal cancer is associated with low frequency tumor budding and improved outcome
- (2015) Viktor H. Koelzer et al. Translational Research
- Prognostic value of HLA class I expression in patients with colorectal cancer
- (2015) Yuji Iwayama et al. World Journal of Surgical Oncology
- Decitabine Enhances Lymphocyte Migration and Function and Synergizes with CTLA-4 Blockade in a Murine Ovarian Cancer Model
- (2015) L. Wang et al. Cancer Immunology Research
- HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
- (2015) D. M. Woods et al. Cancer Immunology Research
- Antitumor activity of epigenetic immunomodulation combined with CTLA-4 blockade in syngeneic mouse models
- (2015) A Covre et al. OncoImmunology
- IFNγ producing CD8+T cells modified to resist major immune checkpoints induce regression of MHC class I-deficient melanomas
- (2015) Michel Buferne et al. OncoImmunology
- Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencing
- (2015) Miran Jang et al. OncoImmunology
- Epigenetic regulations in the IFNγ signalling pathway: IFNγ-mediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigen-presenting machinery genes
- (2015) Veronika Vlková et al. Oncotarget
- Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers
- (2015) Huili Li et al. Oncotarget
- Characterization of β2-microglobulin expression in different types of breast cancer
- (2014) Kesheng Li et al. BMC CANCER
- Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study
- (2014) Marlies S Reimers et al. BMC CANCER
- Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition
- (2014) A B del Campo et al. CANCER GENE THERAPY
- MHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment In Vitro
- (2014) T. E. Angell et al. CLINICAL CANCER RESEARCH
- Reduced expression of members of the MHC-I antigen processing machinery in ethnic Uighur women with cervical cancer in the Xinjiang region of China
- (2014) A. Haimiti et al. Current Oncology
- Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma
- (2014) Ola H Nada et al. Diagnostic Pathology
- Cytokine therapy reverses NK cell anergy in MHC-deficient tumors
- (2014) Michele Ardolino et al. JOURNAL OF CLINICAL INVESTIGATION
- ERAP1–ERAP2 Dimerization Increases Peptide-Trimming Efficiency
- (2014) Irini Evnouchidou et al. JOURNAL OF IMMUNOLOGY
- HLA Class I Expression and Its Alteration by Preoperative Hyperthermo-Chemoradiotherapy in Patients with Rectal Cancer
- (2014) Hiro Sato et al. PLoS One
- Survivin and HLA-I expression predicts survival of patients with clear cell renal cell carcinoma
- (2014) Sulai Liu et al. TUMOR BIOLOGY
- Expression of HLA Class I Antigen, Aspirin Use, and Survival After a Diagnosis of Colon Cancer
- (2014) Marlies S. Reimers et al. JAMA Internal Medicine
- Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer
- (2014) K. Odunsi et al. Cancer Immunology Research
- Prognostic Impact of Human Leukocyte Antigen Class I Expression and Association of Platinum Resistance with Immunologic Profiles in Epithelial Ovarian Cancer
- (2014) T. Mariya et al. Cancer Immunology Research
- A Role for Naturally Occurring Alleles of Endoplasmic Reticulum Aminopeptidases in Tumor Immunity and Cancer Pre-Disposition
- (2014) Efstratios Stratikos et al. Frontiers in Oncology
- TAP expression level in tumor cells defines the nature and processing of MHC class I peptides for recognition by tumor-specific cytotoxic T lymphocytes
- (2013) Faten El Hage et al. Annals of the New York Academy of Sciences
- miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells
- (2013) Fei Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
- (2013) E C M Zeestraten et al. BRITISH JOURNAL OF CANCER
- Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors
- (2013) S. Rusakiewicz et al. CANCER RESEARCH
- Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma
- (2013) Ana B. del Campo et al. INTERNATIONAL JOURNAL OF CANCER
- ERAAP and Tapasin Independently Edit the Amino and Carboxyl Termini of MHC Class I Peptides
- (2013) T. Kanaseki et al. JOURNAL OF IMMUNOLOGY
- The MAPK Pathway Is a Predominant Regulator of HLA-A Expression in Esophageal and Gastric Cancer
- (2013) K. Mimura et al. JOURNAL OF IMMUNOLOGY
- Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway
- (2013) Louise H. Boyle et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Perforinopathy: A Spectrum of Human Immune Disease Caused by Defective Perforin Delivery or Function
- (2013) Ilia Voskoboinik et al. Frontiers in Immunology
- Down-regulation of human leukocyte antigen class I (HLA-I) is associated with poor prognosis in patients with clear cell renal cell carcinoma
- (2012) Jinyang Yuan et al. ACTA HISTOCHEMICA
- Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer
- (2012) Sumiya Ishigami et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes
- (2012) Monica Bernal et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The RNA-binding E3 ubiquitin ligase MEX-3C links ubiquitination with MHC-I mRNA degradation
- (2012) Florencia Cano et al. EMBO JOURNAL
- Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma
- (2012) X. Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Clinical significance of human leukocyte antigen loss and melanoma-associated antigen 4 expression in smokers of non-small cell lung cancer patients
- (2012) Tetsuro Baba et al. International Journal of Clinical Oncology
- Cutting Edge: Impaired MHC Class I Expression in Mice Deficient for Nlrc5/Class I Transactivator
- (2012) A. Biswas et al. JOURNAL OF IMMUNOLOGY
- Establishment of a monoclonal anti-pan HLA class I antibody suitable for immunostaining of formalin-fixed tissue: Unusually high frequency of down-regulation in breast cancer tissues
- (2012) Toshihiko Torigoe et al. PATHOLOGY INTERNATIONAL
- Post-Transcriptional and Epigenetic Regulation of Antigen Processing Machinery (APM) Components and HLA-I in Cervical Cancers from Uighur Women
- (2012) Ayshamgul Hasim et al. PLoS One
- In-Depth Investigation of Archival and Prospectively Collected Samples Reveals No Evidence for XMRV Infection in Prostate Cancer
- (2012) Deanna Lee et al. PLoS One
- IRF1 and NF-kB Restore MHC Class I-Restricted Tumor Antigen Processing and Presentation to Cytotoxic T Cells in Aggressive Neuroblastoma
- (2012) Silvia Lorenzi et al. PLoS One
- The role of classical and non-classical HLA class I antigens in human tumors
- (2012) Juergen Bukur et al. SEMINARS IN CANCER BIOLOGY
- Targeting HLA class I expression to increase tumor immunogenicity
- (2012) A. B. del Campo et al. TISSUE ANTIGENS
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Clinical implication of HLA class I expression in breast cancer
- (2011) Koichi Kaneko et al. BMC CANCER
- Genome-wide differential genetic profiling characterizes colorectal cancers with genetic instability and specific routes to HLA class I loss and immune escape
- (2011) Mónica Bernal et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
- (2011) S. Platonova et al. CANCER RESEARCH
- Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice
- (2011) B. L. Mundy-Bosse et al. CANCER RESEARCH
- Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival
- (2011) T. Tsuchikawa et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients
- (2011) KIMITAKA TANAKA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
- (2011) Tangying Lu et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic Significance of HLA Class I Expressing in Gastric Carcinoma Defined by Monoclonal Anti-Pan HLA Class I Antibody, EMR8-5
- (2011) Hae-Wan Lee et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Mice completely lacking immunoproteasomes show major changes in antigen presentation
- (2011) Eleanor Z Kincaid et al. NATURE IMMUNOLOGY
- Altered HLA Class I and HLA-G Expression Is Associated with IL-10 Expression in Patients with Cervical Cancer
- (2011) Josefa Antonia Rodríguez et al. PATHOBIOLOGY
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma
- (2010) T Maruyama et al. BRITISH JOURNAL OF CANCER
- Perforin deficiency and susceptibility to cancer
- (2010) A J Brennan et al. CELL DEATH AND DIFFERENTIATION
- The Predictive Value of HLA Class I Tumor Cell Expression and Presence of Intratumoral Tregs for Chemotherapy in Patients with Early Breast Cancer
- (2010) E. M. de Kruijf et al. CLINICAL CANCER RESEARCH
- Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancer
- (2010) J. A. D. Simpson et al. GUT
- Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer
- (2010) Atsuko Kasajima et al. HUMAN PATHOLOGY
- Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors
- (2010) Isabel Maleno et al. IMMUNOGENETICS
- T cell recognition of HLA-A2 restricted tumor antigens is impaired by the oncogene HER2
- (2010) Kousaku Mimura et al. INTERNATIONAL JOURNAL OF CANCER
- Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells
- (2010) Rafael Carretero et al. INTERNATIONAL JOURNAL OF CANCER
- Characterizing the Specificity and Cooperation of Aminopeptidases in the Cytosol and Endoplasmic Reticulum during MHC Class I Antigen Presentation
- (2010) A. Hearn et al. JOURNAL OF IMMUNOLOGY
- HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients
- (2010) E. M. de Kruijf et al. JOURNAL OF IMMUNOLOGY
- Prognostic significance of HLA class I expression in Ewing's sarcoma family of tumors
- (2010) Hiroki Yabe et al. JOURNAL OF SURGICAL ONCOLOGY
- HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis
- (2010) Bandoh ONCOLOGY REPORTS
- NLR family member NLRC5 is a transcriptional regulator of MHC class I genes
- (2010) T. B. Meissner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Beta-2-microglobulin expression correlates with high-grade prostate cancer and specific defects in androgen signaling
- (2010) Sheldon R. Mink et al. PROSTATE
- Downregulation of tapasin expression in primary human oral squamous cell carcinoma: association with clinical outcome
- (2010) Qian Jiang et al. TUMOR BIOLOGY
- Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy
- (2009) M Shehata et al. BRITISH JOURNAL OF CANCER
- Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer
- (2009) Barbara Seliger et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824
- (2009) D. D. Vo et al. CANCER RESEARCH
- Human leukocyte antigen class I down-regulation in muscle-invasive bladder cancer: Its association with clinical characteristics and survival after cystectomy
- (2009) Ichiya Homma et al. CANCER SCIENCE
- Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and β2-microglobulin downregulation in breast cancer
- (2009) Anna Morabito et al. HUMAN IMMUNOLOGY
- Cancer incidence and risk factors after solid organ transplantation
- (2009) Claire M. Vajdic et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Mechanisms of IFN-γ to Up-Regulate MHC Class I Antigen Processing and Presentation
- (2009) Fang Zhou INTERNATIONAL REVIEWS OF IMMUNOLOGY
- ERp57 Modulates STAT3 Signaling from the Lumen of the Endoplasmic Reticulum
- (2009) Helen Coe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
- (2009) Franck Pagès et al. JOURNAL OF CLINICAL ONCOLOGY
- MUTYH-associated polyposis carcinomas frequently lose HLA class I expression-a common event amongst DNA-repair-deficient colorectal cancers
- (2009) Noel FCC de Miranda et al. JOURNAL OF PATHOLOGY
- Use of tumour-responsive T cells as cancer treatment
- (2009) Mary L Disis et al. LANCET
- Down-regulation of HLA class I antigen-processing machinery components in esophageal squamous cell carcinomas: Association with disease progression
- (2009) Qiao Liu et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Efficient Recovery of HLA Class I Expression in Human Tumor Cells After Beta2-Microglobulin Gene Transfer Using Adenoviral Vector: Implications for Cancer Immunotherapy
- (2009) A. B. del Campo et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue
- (2009) P. Sáenz-López et al. TISSUE ANTIGENS
- Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer
- (2009) Q. Ye et al. TISSUE ANTIGENS
- Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma
- (2008) Y Mizukami et al. BRITISH JOURNAL OF CANCER
- Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of Tumors
- (2008) A. F. Setiadi et al. CANCER RESEARCH
- Human Leukocyte Antigen-G and Cancer Immunoediting
- (2008) M. Urosevic et al. CANCER RESEARCH
- HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma
- (2008) L. Y. Han et al. CLINICAL CANCER RESEARCH
- Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation
- (2008) Ninke Leffers et al. GYNECOLOGIC ONCOLOGY
- Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy
- (2008) Rafael Carretero et al. IMMUNOGENETICS
- Immune-mediated dormancy: an equilibrium with cancer
- (2008) Michele W. L. Teng et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma
- (2008) JN Kloth et al. JOURNAL OF PATHOLOGY
- HLA-class I expression in gastric cancer
- (2008) Sumiya Ishigami et al. JOURNAL OF SURGICAL ONCOLOGY
- Clinical significance of HLA class I heavy chain expression in patients with gastric cancer
- (2008) Yoshitake Ueda et al. JOURNAL OF SURGICAL ONCOLOGY
- Loss of heterozygosity at6p21underling HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas
- (2008) Y. Yang et al. TISSUE ANTIGENS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started